Mode of Delivery in Women With Low-lying Placenta
Launched by UNIVERSITY OF MILANO BICOCCA · Mar 29, 2021
Trial Information
Current as of May 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the best way to deliver babies for women who have a low-lying placenta or placenta previa, which is when the placenta is positioned too close to or over the cervix. The trial is looking for women aged 18 and older who are pregnant and have been diagnosed with either of these conditions through an ultrasound. The researchers want to understand how different delivery methods might affect outcomes for both mothers and babies. Women with a normally placed placenta will also be included as a comparison group.
If you decide to participate, you'll be asked to sign consent to join the study. You'll be monitored over time, and if you have any vaginal bleeding before 32 weeks of pregnancy but do not need an emergency delivery, you may be eligible. The study is currently recruiting participants, and being part of this research could help improve care for future mothers facing similar pregnancy issues.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Minimum age of 18
- • Women with placenta previa or low-lying placenta confirmed by TVS at 19-23 6/7 weeks of gestation.
- • Women attending Maternity Triage with vaginal bleeding at \< 32 weeks of gestation, with a diagnosis of placenta previa or low-lying placenta and not requiring an emergency delivery.
- • Women with a normally located placenta at the II trimester ultrasound scan, at 19-23 6/7 week of gestation (control group)
- • Single pregnancy
- • Signature of the informed consent to participate in the study
- • Note: Women of the "control group" will be recruited in a 1:3 ratio. After the inclusion of 1 case, 3 women with a normally located placenta will be recruited, according to the parity of the woman representing the case (e.g.: 1 CASE= nulliparous woman, 3 CONTROLS= 3 nulliparous women).
- Exclusion Criteria:
- • Suspected or confirmed invasive placentation (i.e., placenta accreta)
- • Vaginal bleeding requiring emergency delivery
- • Inability to meet the conditions set out in the study protocol
About University Of Milano Bicocca
The University of Milano-Bicocca is a distinguished academic institution renowned for its commitment to advancing research and education in the biomedical sciences. With a strong emphasis on interdisciplinary collaboration, the university fosters innovative clinical trials that aim to enhance patient care and medical outcomes. Its research initiatives are supported by state-of-the-art facilities and a dedicated team of experts, positioning the University of Milano-Bicocca as a leading sponsor in the realm of clinical trials, dedicated to translating scientific discoveries into practical applications for the benefit of society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milano, , Italy
Milan, , Italy
Bergamo, , Italy
Milan, , Italy
Modena, , Italy
Brescia, , Italy
Modena, , Italy
Rimini, , Italy
Brescia, , Italy
Carate Brianza, , Italy
Cesena, , Italy
Desio, , Italy
Lecco, , Italy
Milano, , Italy
Milan, , Italy
Milan, , Italy
Monza, , Italy
Varese, , Italy
Patients applied
Trial Officials
Sara Ornaghi
Principal Investigator
sara.ornaghi@unimib.it
Patrizia Vergani
Study Director
patrizia.vergani@unimib.it
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials